| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.009 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |